PHASE II CLINICAL TRIAL OF A GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-ENCODING, SECOND-GENERATION ONCOLYTIC HERPESVIRUS

There are eight hallmark biological capabilities necessary for cancer development and persistence: (1) sustained proliferation, (2) evasion of growth suppressors, (3) death resistance ...

The personalization of oncology treatments demands the alignment of patients’ molecular cancer growth mechanisms with the drugs which have been designed to target the cancer specific molecular signals.

The most common way people give up their power is by thinking they don't have any.